Works matching DE "DEOXYCYTIDINE"


Results: 546
    1
    2

    How to 'PrEP' for HIV Prevention in Women.

    Published in:
    Journal of Women's Health (15409996), 2017, v. 26, n. 2, p. 195, doi. 10.1089/jwh.2016.6318
    By:
    • Ntim, Gifty-Maria J.;
    • Kransdorf, Lisa N.
    Publication type:
    Article
    3
    4
    5

    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

    Published in:
    2018
    By:
    • Wu, Yi-Long;
    • Sequist, Lecia V;
    • Tan, Eng-Huat;
    • Geater, Sarayut L;
    • Orlov, Sergey;
    • Zhang, Li;
    • Lee, Ki Hyeong;
    • Tsai, Chun-Ming;
    • Kato, Terufumi;
    • Barrios, Carlos H;
    • Schuler, Martin;
    • Hirsh, Vera;
    • Yamamoto, Nobuyuki;
    • O'Byrne, Kenneth;
    • Boyer, Michael;
    • Mok, Tony;
    • Peil, Barbara;
    • Märten, Angela;
    • Chih-Hsin Yang, James;
    • Paz-Ares, Luis
    Publication type:
    journal article
    6
    7
    8
    9

    Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.

    Published in:
    2017
    By:
    • Santarpia, Mariacarmela;
    • Ramirez, Jose Luis;
    • de Aguirre, Itziar;
    • Garrido, Pilar;
    • Pérez Cano, Maria;
    • Queralt, Cristina;
    • Gonzalez-Larriba, Jose Luis;
    • Insa, Amelia;
    • Provencio, Mariano;
    • Isla, Dolores;
    • Camps, Carlos;
    • Blanco, Remei;
    • Moran, Teresa;
    • Rosell, Rafael;
    • Spanish Lung Cancer Group
    Publication type:
    journal article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Late-onset thymidine kinase 2 deficiency: a review of 18 cases.

    Published in:
    2019
    By:
    • Domínguez-González, Cristina;
    • Hernández-Laín, Aurelio;
    • Rivas, Eloy;
    • Hernández-Voth, Ana;
    • Sayas Catalán, Javier;
    • Fernández-Torrón, Roberto;
    • Fuiza-Luces, Carmen;
    • García García, Jorge;
    • Morís, Germán;
    • Olivé, Montse;
    • Miralles, Frances;
    • Díaz-Manera, Jordi;
    • Caballero, Candela;
    • Méndez-Ferrer, Bosco;
    • Martí, Ramon;
    • García Arumi, Elena;
    • Badosa, María Carmen;
    • Esteban, Jesús;
    • Jimenez-Mallebrera, Cecilia;
    • Encinar, Alberto Blazquez
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36

    A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1053-z
    By:
    • Salazar, Ramon;
    • Capdevila, Jaume;
    • Laquente, Berta;
    • Manzano, Jose Luis;
    • Pericay, Carles;
    • Villacampa, Mercedes Martínez;
    • López, Carlos;
    • Losa, Ferran;
    • Safont, Maria Jose;
    • Gómez, Auxiliadora;
    • Alonso, Vicente;
    • Escudero, Pilar;
    • Gallego, Javier;
    • Sastre, Javier;
    • Grávalos, Cristina;
    • Biondo, Sebastiano;
    • Palacios, Amalia;
    • Aranda, Enrique
    Publication type:
    Article
    37
    38
    39
    40
    41

    Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-323
    By:
    • Buchler, Tomas;
    • Pavlik, Tomas;
    • Melichar, Bohuslav;
    • Bortlicek, Zbynek;
    • Usiakova, Zuzana;
    • Dusek, Ladislav;
    • Kiss, Igor;
    • Kohoutek, Milan;
    • Benesova, Vera;
    • Vyzula, Rostislav;
    • Abrahamova, Jitka;
    • Obermannova, Radka
    Publication type:
    Article
    42

    Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-277
    By:
    • Vamvakas, Lambros;
    • Matikas, Alexios;
    • Karampeazis, Athanasios;
    • Hatzidaki, Dora;
    • Kakolyris, Stelios;
    • Christophylakis, Charalampos;
    • Boukovinas, Ioannis;
    • Polyzos, Aris;
    • Georgoulias, Vassilis;
    • Souglakos, John
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50